Page last updated: 6 July 2021
From 1 April 2021 the management of Authorised Representative details must be undertaken using the Health Products Portal (HPP). Please see the Getting started in the HPP, quick reference guide for further instructions.
An Authorised Representative is an individual who has the legal authority to act on behalf of the Responsible Person.
The authority of the Authorised Representative extends to all of the Responsible Person obligations (price negotiation and agreements, price disclosure, guarantee of supply and change of Responsible Person details). Each Responsible Person must have at least one Authorised Representative; however, an individual can be the Authorised Representative for more than one Responsible Person. All correspondence from the Department to a Responsible Person will be directed to its Authorised Representatives.
Where there are any additions or changes to PBS items for a Responsible Person, a Summary of Changes (SoC) is provided to Authorised Representatives ‘under embargo’. The SoC is provided on the condition that the information will not be publicly released before the effective date of the relevant changes to the Schedule of Pharmaceutical Benefits. Authorised Representatives may undertake limited distribution of this embargoed information to finalise materials to allow availability and prescribing of its products on the effective listing date. ‘Under embargo’ requirements also extend to any general correspondence between Authorised Representatives and the Department of Health pertaining to affected PBS items. Any person to whom this information is released must also follow the ‘under embargo’ requirements.